These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 5972710
1. [On the clinical diagnosis of amyloidosis]. Senn HJ, Heiniger HJ, Bürki H, Rieder U. Schweiz Med Wochenschr; 1966 Oct 15; 96(41):1363-74. PubMed ID: 5972710 [No Abstract] [Full Text] [Related]
4. [Clinical manifestations of AL-amyloidosis and some other types of amyloidosis]. Adam Z, Scudla V. Vnitr Lek; 2001 Jan 20; 47(1):36-45. PubMed ID: 15635867 [Abstract] [Full Text] [Related]
7. [Amyloidosis. Etiology and clinical manifestations]. Schouten JA. Ned Tijdschr Tandheelkd; 1995 Feb 20; 102(2):52-4. PubMed ID: 11837071 [Abstract] [Full Text] [Related]
8. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Westermark P, Davey E, Lindbom K, Enqvist S. Acta Histochem; 2006 Feb 20; 108(3):209-13. PubMed ID: 16714055 [Abstract] [Full Text] [Related]
9. [Diagnosis of amyloidosis]. Droz D. Rev Prat; 1997 Oct 15; 47(16):1773-6. PubMed ID: 9453201 [Abstract] [Full Text] [Related]
10. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E, Gavazzi A, Merlini G. Ital Heart J Suppl; 2002 Jun 15; 3(6):590-7. PubMed ID: 12116807 [Abstract] [Full Text] [Related]
11. [AL amyloidosis]. Hedeshi AR, Brenez D, Benaddia L, Vandervelde D, Khodadadi E, Ardichvili D, Malarme M. Rev Med Brux; 2001 Feb 15; 22(1):9-14. PubMed ID: 11252906 [Abstract] [Full Text] [Related]
13. [Diagnostic difficulties and adverse effects of prednisone in amyloid nephrosis with beta globulin paraproteinemia]. Dyk T, Bajena S. Pol Tyg Lek; 1966 Feb 14; 21(7):267-9. PubMed ID: 4160346 [No Abstract] [Full Text] [Related]
14. [Advances in diagnosis and treatment of AL amyloidosis]. Zelichowski G, Lubas A, Wańkowicz Z. Pol Merkur Lekarski; 2008 Apr 14; 24(142):340-5. PubMed ID: 18634370 [Abstract] [Full Text] [Related]
15. [Diagnosis and treatment in systemic amyloidosis]. Ikeda S. Rinsho Byori; 2008 Feb 14; 56(2):121-9. PubMed ID: 18404826 [Abstract] [Full Text] [Related]
16. [Amyloidosis in patients with rheumatoid arthritis]. Bluszcz-Roznowska A, Kucharz EJ. Przegl Lek; 2005 Feb 14; 62(12):1532-7. PubMed ID: 16786790 [Abstract] [Full Text] [Related]
17. [Whipple's disease--a rare cause of secondary amyloidosis]. Leidig P, Stolte M, Krakamp B, Störkel S. Z Gastroenterol; 1994 Feb 14; 32(2):109-12. PubMed ID: 7513114 [Abstract] [Full Text] [Related]
18. [Classification of amyloidosis]. Husby G. Tidsskr Nor Laegeforen; 1996 Jan 20; 116(2):234-7. PubMed ID: 8633331 [Abstract] [Full Text] [Related]
19. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis. Maezawa A, Hiromura K, Mitsuhashi H, Tsukada Y, Kanai H, Yano S, Naruse T. Clin Nephrol; 1994 Jul 20; 42(1):30-2. PubMed ID: 7923963 [Abstract] [Full Text] [Related]